AIDS

1. DADABHAI S, Chou VB, Pinilla M, Chinula L, et al
   Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trial.
   AIDS. 2024 Mar 4. doi: 10.1097/QAD.0000000000003878.
   

   >> Share

   
   
2. DICKSON S, James K
   Trends in HIV preexposure prophylaxis utilization and spending among individuals with commercial insurance.
   AIDS. 2024;38:610-612.
   

   >> Share

   
   
3. SHIVAKOTI R, Giganti MJ, Lederman MM, Ketchum R, et al
   Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery.
   AIDS. 2024 Feb 26. doi: 10.1097/QAD.0000000000003877.
   

   >> Share

   
   

   
   Clin Infect Dis

4. SHAH MM, Joyce B, Plumb ID, Sahakian S, et al
   Combined protection of vaccination and nirmatrelvir-ritonavir against hospitalization in adults with COVID-19.
   Clin Infect Dis. 2024 Feb 27:ciae105. doi: 10.1093.
   

   >> Share

   
   

   
   J Acquir Immune Defic Syndr

5. VAN HEERDEN JK, Meintjes G, Barr D, Zhao Y, et al
   Relationship Between Tenofovir Diphosphate Concentrations in Dried Blood Spots and Virological Outcomes After Initiating Tenofovir-Lamivudine-Dolutegravir as First-Line or Second-Line Antiretroviral Therapy.
   J Acquir Immune Defic Syndr. 2024;95:260-267.
   

   >> Share

   
   

   
   JAMA

6. MARRAZZO J, Tao L, Becker M, Leech AA, et al
   HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women.
   JAMA. 2024 Mar 1. doi: 10.1001/jama.2024.0464.
   

   >> Share

   
   
7. SARPATWARI A, Kohli S, Tu SS, Kesselheim AS, et al
   Patents on Risk Evaluation and Mitigation Strategies for Prescription Drugs and Generic Competition.
   JAMA. 2024 Feb 22:e240924. doi: 10.1001/jama.2024.0924.
   

   >> Share

   
   

   
   PLoS One

8. MINJA M, Mbilinyi T, Mkinga B, Philipo EG, et al
   Prevalence, treatment, and factors associated with cryptococcal meningitis post introduction of integrase inhibitors antiretroviral based regimens among People Living with HIV in Tanzania.
   PLoS One. 2024;19:e0294940.
   

   >> Share

   
   
9. SHAMU T, Egger M, Mudzviti T, Chimbetete C, et al
   Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal study.
   PLoS One. 2024;19:e0293162.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share